Genor Biopharma Holdings Limited 嘉和生物藥業(開曼)控股有限公司

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Wen (1969) 陳文 INED 420 420
2 Chen, Yu (SFC:AQQ907) 陳宇 NED
3 Fung, Edwin 馮冠豪 INED 420 420
4 Guo, Feng (1970) 郭峰 Ch, CEO 5,864 1,500 24,813 32,177
5 Liu, Yi (1989) 劉逸 NED
6 Lyu, Dong (1975) 呂東 NED
7 Ni, Lin (1974) 倪琳 NED
8 Zhou, Honghao 周宏灝 INED 420 420
9 Zhou, Joe Xin Hua 周新華 Pres 730 730
Total 1,260 6,594 1,500 0 24,813 34,167

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,260 6,742 1,246 0 12,809 22,057 Report
2023-12-31 1,260 6,168 1,500 0 16,617 25,545 Report
2022-12-31 1,260 6,594 1,500 0 24,813 34,167 Report
2021-12-31 0 10,319 2,228 0 33,658 46,205 Report
2020-12-31 0 6,751 2,448 0 101,137 110,336 Report
Total 3,780 36,574 8,922 0 189,034 238,310

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top